You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

KMT2A/MLL Gene Rearrangement

Showing 1 - 25 of 6,090
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed/Refractory Leukemias, Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia Trial in Kansas City, Cincinnati

Recruiting
  • Relapsed/Refractory Leukemias
  • +4 more
  • Kansas City, Missouri
  • +1 more
Jul 18, 2022

Acute Myeloid Leukemia With KMT2A Rearrangement, Acute Myeloid Leukemia With NPM1 Mutation Trial (Biospecimen Collection, Bone

Not yet recruiting
  • Acute Myeloid Leukemia With KMT2A Rearrangement
  • Acute Myeloid Leukemia With NPM1 Mutation
  • Biospecimen Collection
  • +7 more
  • (no location specified)
Jun 1, 2023

AML, AML With Mutated NPM1, Hematologic Malignancy Trial (Ziftomenib, Fludarabine, Idarubicin)

Not yet recruiting
  • AML
  • +11 more
  • (no location specified)
Aug 14, 2023

Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute Trial in Japan, United States (DSP-5336)

Recruiting
  • Leukemia, Myeloid, Acute
  • Leukemia, Lymphocytic, Acute
  • Houston, Texas
  • +5 more
May 31, 2022

Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Mixed Phenotype Acute Leukemia

Not yet recruiting
  • Recurrent Acute Leukemia of Ambiguous Lineage
  • +5 more
  • Biospecimen Collection
  • +12 more
  • (no location specified)
Mar 8, 2023

Acute Myeloid Leukemia, Mixed Lineage Acute Leukemia, Mixed Lineage Leukemia Gene Mutation Trial (Ziftomenib, Venetoclax,

Not yet recruiting
  • Acute Myeloid Leukemia
  • +10 more
  • (no location specified)
Feb 17, 2023

People Who Have Genetic Changes and Features of Autism: Simons

Recruiting
  • 16P11.2 Deletion Syndrome
  • +184 more
    • New York, New York
    • +1 more
    Jan 6, 2023

    Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia Trial in Worldwide

    Active, not recruiting
    Has Results
    • Acute Leukemia of Ambiguous Lineage
    • +2 more
    • Birmingham, Alabama
    • +173 more
    Nov 16, 2021

    Nsclc, EGFR Activating Mutation, EGF-R Positive NSCLC Trial in Hong Kong (Pembrolizumab, Lenvatinib, Pemetrexed)

    Recruiting
    • Nsclc
    • +5 more
    • Hong Kong, Hong Kong
      Queen Mary Hospital
    Nov 25, 2021

    Leukemia, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Canada, United States (EPZ-5676)

    Completed
    • Leukemia
    • +3 more
    • Los Angeles, California
    • +8 more
    May 7, 2020

    High-grade B-cell Lymphoma, Burkitt Lymphoma, Lymphoma, B-Cell Trial in Busan, Seoul (Sepantronium Bromide)

    Not yet recruiting
    • High-grade B-cell Lymphoma
    • +8 more
    • Sepantronium Bromide
    • Busan, Korea, Republic of
    • +5 more
    Feb 27, 2022

    Acute Leukemias, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Worldwide (JNJ-75276617)

    Recruiting
    • Acute Leukemias
    • +2 more
    • Duarte, California
    • +28 more
    Jan 27, 2023

    Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A, Fibroblast Growth Factor Basic Form Measurement, FLT3 Internal

    Recruiting
    • Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A
    • +4 more
    • Chicago, Illinois
      Northwestern University
    Apr 30, 2021

    Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Atlanta, Ann Arbor, Saint Louis (Dexamethasone, Ixazomib,

    Active, not recruiting
    • Recurrent Plasma Cell Myeloma
    • Refractory Plasma Cell Myeloma
    • Atlanta, Georgia
    • +3 more
    Jan 6, 2023

    Advanced Cholangiocarcinoma, FGFR2 Fusions, Gene Rearrangement Trial (TAS-120)

    Not yet recruiting
    • Advanced Cholangiocarcinoma
    • +2 more
    • (no location specified)
    Feb 3, 2023

    Cancer, Cancer Metastatic, NTRK Gene Fusion Overexpression Trial in Worldwide (Data collection and quality of life

    Recruiting
    • Cancer
    • +15 more
    • Data collection and quality of life questionnaire
    • Graz, Austria
    • +40 more
    Jul 27, 2021

    Acute Lymphoblastic Leukemia, Pediatric, ALL, Infants Trial (the risk-adapted choice of therapy and the use of a combination of

    Not yet recruiting
    • Acute Lymphoblastic Leukemia, Pediatric
    • ALL, Infants
    • the risk-adapted choice of therapy and the use of a combination of chemotherapy with immunotherapy and hematopoietic stem cell transplantation for patients with risk factors.
    • (no location specified)
    Aug 26, 2021

    Pediatric and Young Adult Patientswith Hypodiploid or t(17;19) B-ALL, Infants With Very High Risk KMT2A B-ALL, Patients With CNS

    Active, not recruiting
    • Pediatric and Young Adult Patientswith Hypodiploid or t(17;19) B-ALL
    • +2 more
    • Murine CART19
    • Philadelphia, Pennsylvania
      Children's Hospital of Philadelphia
    Jan 11, 2022

    Study of miRNA-155 in Acute Leukemia

    Not yet recruiting
    • Acute Leukemia
    • BM aspirate
    • (no location specified)
    Mar 30, 2023

    Locally Advanced Solid Tumors, Metastatic Solid Tumors Trial in Worldwide (Oral repotrectinib (TPX-0005))

    Recruiting
    • Locally Advanced Solid Tumors
    • Metastatic Solid Tumors
    • Oral repotrectinib (TPX-0005)
    • Yuma, Arizona
    • +175 more
    Jan 25, 2023

    Healthy Volunteers Trial in Limoges (Blood sample)

    Completed
    • Healthy Volunteers
    • Blood sample
    • Limoges, France
      Limoges University Hospital
    Oct 18, 2021

    ALK Gene Rearrangement, EGFR Gene Mutation, Locally Advanced Lung Non-Small Cell Carcinoma Trial in Houston (Ipilimumab,

    Recruiting
    • ALK Gene Rearrangement
    • +11 more
    • Ipilimumab
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 2, 2020

    Radiotherapy Side Effect, NSCLC, ALK Gene Mutation Trial in Stockholm (SBRT/SRS/radiation therapy)

    Not yet recruiting
    • Radiotherapy Side Effect
    • +2 more
    • SBRT/SRS/radiation therapy
    • Stockholm, Sweden
      Karolinska University Hospital
    Feb 16, 2023

    ALL, Adult, AML, Adult Trial (BN104)

    Not yet recruiting
    • ALL, Adult
    • AML, Adult
    • (no location specified)
    Sep 19, 2023

    NSCLC Trial in Suzhou (Pemigatinib)

    Recruiting
    • Non-Small Cell Lung Cancer
    • Suzhou, China
      The First Affiliated Hospital of Soochow University
    Jan 14, 2022